Pacira BioSciences, Inc.
PCRX
$27.00
-$0.14-0.52%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -35.50% | -1,421.29% | -26.69% | 145.96% | 346.19% |
| Total Depreciation and Amortization | 14.92% | 9.87% | -1.00% | -6.00% | -7.14% |
| Total Amortization of Deferred Charges | 22.43% | 21.89% | 9.32% | -56.27% | -66.92% |
| Total Other Non-Cash Items | 0.76% | 669.32% | 357.37% | -61.17% | -40.66% |
| Change in Net Operating Assets | -55.52% | 125.46% | 29.39% | 151.59% | -608.93% |
| Cash from Operations | -30.37% | 21.34% | 22.38% | 156.70% | 13.20% |
| Capital Expenditure | -17.80% | -20.57% | 53.29% | 56.80% | 67.26% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -82.80% | -4,970.78% | -226.98% | -117.45% | -39.02% |
| Cash from Investing | -104.39% | -1,101.36% | -307.68% | -123.47% | -25.16% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 89.89% | -7,096.84% | 99.05% | 95.26% |
| Issuance of Common Stock | -18.00% | -100.00% | -58.07% | -- | -44.14% |
| Repurchase of Common Stock | 27.36% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | -9.89% | 89.76% | 5,577.27% | 98.17% | 96.96% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -43.13% | -108.84% | 22.89% | 144.83% | 1,125.15% |